Evidence map›Paper›PMID 41416843›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Predictors of Abnormal Diffusing Capacity for Carbon Monoxide in Post-pneumonia Ugandans With and Without HIV.

Katerina L Byanova, Jessica Fitzpatrick, Josephine Zawedde, Patrick Byanyima, Ingvar Sanyu, Michelle H Zhang, Jake Branchini, Elinor Velasquez, Rebecca Abelman, Abdulwahab Sessolo and 7 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Katerina L ByanovaDepartment of Critical Care Medicine, Swedish Medical Center, Seattle, WA.ORCID 0000-0001-6739-1120
Jessica FitzpatrickDivision of Rheumatology, University of California San Francisco, San Francisco, CA.
Josephine ZaweddeInfectious Diseases Research Collaboration, Kampala, Uganda.
Patrick ByanyimaInfectious Diseases Research Collaboration, Kampala, Uganda.
Ingvar SanyuInfectious Diseases Research Collaboration, Kampala, Uganda.
Michelle H ZhangDivision of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA.
Jake BranchiniDivision of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA.
Elinor VelasquezDivision of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA.
Rebecca AbelmanDivision of Infectious Diseases, University of California San Francisco, San Francisco, CA.
Abdulwahab SessoloInfectious Diseases Research Collaboration, Kampala, Uganda.
Jue LinDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA.
Crystal M NorthDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA.
Rejani LalithaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Nirav R BhaktaDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California San Francisco, San Francisco, CA.
Peter W HuntDivision of Experimental Medicine, University of California San Francisco, San Francisco, CA.
William WorodriaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Laurence HuangDivision of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA.

Funding

Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study - Diversity SupplementR01HL128156 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, LAURENCE, HUNT, PETER W · 2015 to 2024
$7.1M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) StudyR01HL143998 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTENSON, STEPHANIE A, HUANG, LAURENCE · 2019 to 2022
$3.2M
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)K12HL143961 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUE, PRISCILLA Y., HUANG, LAURENCE · 2018 to 2022
$1.8M
Isolated Abnormality in the Diffusion Capacity for Carbon Monoxide in People Living with HIV – Epidemiology, Etiology and PathogenesisF32HL166065 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BYANOVA, KATERINA L. · 2022 to 2024
$240k
NHLBI NIH HHS F32 HL166065NHLBI NIH HHS K12 HL143961NHLBI NIH HHS R01 HL128156NHLBI NIH HHS R01 HL128156-08S1NHLBI NIH HHS R01 HL143998NIAID NIH HHS T32 AI060530
6 · The paper itself

Abstract

backgroundAbnormal diffusing capacity for carbon monoxide (DLco) is highly prevalent among people with HIV (PWH) and associated with increased mortality in both PWH and the general population. Because there are no DLco data from East Africa, we characterized the prevalence and risk factors for abnormal DLco in PWH and people without HIV (PWoH) in Uganda.

settingKampala, Uganda.

methodsWe performed a cross-sectional analysis of adults with and without HIV, who were followed longitudinally for lung function change after pneumonia. We used the participants' first American Thoracic Society/European Respiratory Society-compliant DLco measurements post pneumonia. We built multivariable linear and logistic regression models to determine predictors of abnormal DLco. We then developed stratified multivariable models to determine whether the predictors of abnormal DLco differ by HIV serostatus.

resultsAmong 447 individuals, 47.9% were PWH, 17.2% were ever cigarette smokers, 71.4% had tuberculosis (TB) on enrollment, and 9.9% had self-reported past TB. The prevalence of abnormal DLco was 21.7%. In adjusted models, HIV was significantly associated with a lower %predicted DLco, as were past bacterial pneumonia, TB (past and on enrollment), and smoking. After stratification and adjustment, TB (past and on enrollment) was significantly associated with a lower %predicted DLco both among PWH and PWoH; smoking was associated with lower DLco among PWoH, and work fumes exposure was associated with higher odds of DLco < lower limit of normal among PWH only.

conclusionsAbnormal DLco was common post pneumonia in Ugandan adults, and its predictors differed by HIV serostatus. Longitudinal follow-up can help understand the trajectory of and morbidity associated with DLco.

Indexed as

Carbon MonoxideHIV InfectionsPneumoniaPulmonary Diffusing CapacityAdultCross-Sectional StudiesEast African PeopleFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsUgandaCarbon MonoxideDLcoHIVlung impairmentsub-Saharan Africatuberculosis

Identifiers

PMID41416843
PMCPMC12867093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.